Corpus callosum atrophy - A simple predictor of multiple sclerosis progression: A longitudinal 9-year study

European Neurology

Volumn 68, Issue 1, 2012, Pages 23-27

  Vaneckova, M ^a   Kalincik, T ^b   Krasensky, J ^a   Horakova, D ^b   Havrdova, E ^b   Hrebikova, T ^a   Seidl, Z ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Corpus callosum; Magnetic resonance imaging; Monitoring; Multiple sclerosis

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; CORPUS CALLOSUM; DISABILITY; DISEASE COURSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SENSIBILITY;

ADULT; ATROPHY; CORPUS CALLOSUM; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84861798842     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000337683     Document Type: Article

References (19)

1. Ge Y: Multiple sclerosis: the role of MR imag-ing. AJNR Am J Neuroradiol 2006; 27:1165-1176.
2. Barkhof F: The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 2002; 15: 239-245. (Pubitemid 34596884)
3. Horakova D, Dwyer MG, Havrdova E, Cox JL, Dolezal O, Bergsland N, Rimes B, Seidl Z, Vaneckova M, Zivadinov R: Gray matter at-rophy and disability progression in patients with early relapsing-remitting multiple scle-rosis: a 5-year longitudinal study. J Neurol Sci 2009; 282:112-119.
4. Miller DH, Barkhof F, Frank JA, Parker GJM, Thompson AJ: Measurement of atrophy in multiple sclerosis: pathological basis, metho-logical aspects and clinical relevance. Brain 2002; 125:1676-1695.
5. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM: Regional axonal loss in the corpus callosum correlates with cere-bral white matter lesion volume and distri-bution in multiple sclerosis. Brain 2000; 123: 1845-1849. (Pubitemid 30664287)
6. Barkhof FJ, Elton M, Lindeboom J, Tas MW, Schmidt WF, Hommes OR, Polman CH, Kok A, Valk J: Functional correlates of callosal at-rophy in relapsing-remitting multiple sclero-sis patients. A preliminary MRI study. J Neu-rol 1998; 245:153-158. (Pubitemid 28135058)
7. Yaldizli O, Atefy R, Gass A, Sturm D, Glassl S, Tettenborn B, Putzki N: Corpus callosum index and long-term disability in multiple sclerosis patients. J Neurol 2010; 257:1256-1264.
8. Sampat MP, Berger AM, Healy BC, Hilden-brand P, Vass J, Meier DS, Chitnis T, Weiner HL, Bakshi R, Guttmann CR: Regional white matter atrophy-based classification of mul-tiple sclerosis in cross-sectional and longitu-dinal data. AJNR Am J Neuroradiol 2009; 30: 1731-1739.
9. Vaneckova M, Seidl Z, Krasensky J, Oben-berger J, Havrdova E, Vitak T, Danes J: Le-sion load in modus FLAIR (fluid-attenuated inversion recovery) in patients with multiple sclerosis. Ces Slov Neurol Neurochir 2002; 3: 175-179. (Pubitemid 34591543)
10. Vaneckova M, Seidl Z, Krasensky J, Havrdo-va E, Horakova D, Dolezal O, Burgetova A, Masek M: Patients' stratification and corre-lation of brain magnetic resonance imaging parameters with disability progression in multiple sclerosis. Eur Neurol 2009; 61: 278-284.
11. Figueira FF, Santos VS, Figueira GM, Silva AC: Corpus callosum index: a practical method for long-term follow-up in multiple sclerosis. Arq Neuropsiquiatr 2007; 65: 931-935.
12. Lin F, Yu C, Liu Y, Li K, Lei H: Diffusion ten-sor group tractography of the corpus callo-sum in clinically isolated syndrome. AJNR Am J Neuroradiol 2011; 32:92-98.
13. Lin F, Yu C, Jiang T, Li K, Chan P: Diffusion tensor tractography-based group mapping of the pyramidal tract in relapsing-remitting multiple sclerosis patients. AJNR Am J Neu-roradiol 2007; 28: 278-282. (Pubitemid 46281045)
14. Ozturk A, Smith SA, Gordon-Lipkin EM, Harrison DM, Shiee N, Pham DL, Caffo BS, Calabresi PA, Reich DS: MRI of the corpus callosum in multiple sclerosis: association with disability. Mult Scler 2010; 16: 166-177.
15. 1-weighted spin-echo magnetic resonance im-aging: relation to clinical characteristics in subgroups of patients with multiple sclerosis. Arch Neurol 2001; 58: 76-81. (Pubitemid 32053210)
16. 2 relaxometry. Eur Neurol 2010; 63: 136-143.
17. Filippi M, Rocca MA, De Stefano N Enzing-er C, Fisher E, Horsfield MA, Inglese M, Pel-letier D, Comi G: Magnetic resonance tech-niques in multiple sclerosis: the present and the future. Arch Neurol 2011; 68:1514-1520.
18. Barkhof J, Simon JH, Fazekas F, Rovaris M, Kappos L, de Stefano N Polman CH, Petkau J, Radue EW, Sormani MP, Li DK, O'Connor P, Montalban X, Miller DH, Filippi M: MRI monitoring of immunomodulation in re-lapse-onset multiple sclerosis trials. Nat Rev Neurol 2012; 8:13-21.
19. Neema M, Stankiewicz J, Arora A, Guss ZD, Bakshi R: MRI in multiple sclerosis: what's inside the toolbox? Neurotherapeutics 2007; 4:602-617. (Pubitemid 47505349)